Artificial intelligence in hepatitis and chronic liver disease
Loading...
Date
2024
Journal Title
Nanobiotechnology and Artificial Intelligence in Gastrointestinal Diseases
Journal ISSN
Volume Title
Publisher
Institute of Physics Publishing
Abstract
Artificial Intelligence (AI) is a well-developing field of computer science that imitateshuman technical thinking to solve problems. The use of different AI models inhepatology is a recent development in the medical field for better diagnostics.Conventional diagnostic methods are being integrated with modern AI to enhancethe performance of treatment. AI has the ability to mine the data in humanparameters, and forecast the occurrence of hepatitis and other chronic liver diseases.Classifying the different stages of hepatitis, fatty liver disease and hemochromatosisare possible along with diagnosis and screening. Early disease prediction, complications and mortality can be studied using the algorithms such as regression models,since hepatitis early diagnosis is clinically limited in early stages. AI can predict therisk related to the vascular invasion of hepatocellular carcinoma and hepatitisrelated to cirrhosis. It also calculates the liver failure rate in hepatocellularcarcinoma (HCC) patients. Ultimately AI will eventually help in reducing medicalerrors and managing the patient clinical output. � IOP Publishing Ltd 2024. All rights reserved.